CHERYL MUELLER

Allopathic & Osteopathic Physicians|Family Medicine SAN ANTONIO, TX NPI 1528034758

General Payments — all program years on this page

$2,964.99

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 158
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $466.65 across 13 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $466.6513

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Novo Nordisk AS $140.022
Lilly USA, LLC $124.991
Abbott Laboratories $65.143
PFIZER INC. $35.732
Acerta Pharma LLC $33.192
Astellas Pharma US Inc $28.431
Azurity Pharmaceuticals, Inc. $24.591
GlaxoSmithKline, LLC. $14.561

By program year

Program yearAmountRecords
2018 $1,105.5255
2019 $531.0535
2020 $178.6811
2021 $282.1616
2022 $91.246
2023 $309.6922
2024 $466.6513

Records — PY2024 (13)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1097180201 Novo Nordisk Inc $17.32 08/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097588104 Novo Nordisk Inc $122.70 08/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105519341 AstraZeneca Pharmaceuticals LP $18.15 08/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105609627 AstraZeneca Pharmaceuticals LP $15.04 11/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116390882 GlaxoSmithKline, LLC. $14.56 10/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125108406 Abbott Laboratories $22.60 08/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125108408 Abbott Laboratories $21.70 11/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125108410 Abbott Laboratories $20.84 11/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131849653 PFIZER INC. $17.47 08/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131927284 PFIZER INC. $18.26 10/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1134010155 Azurity Pharmaceuticals, Inc. $24.59 06/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136093787 Lilly USA, LLC $124.99 03/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139423377 Astellas Pharma US Inc $28.43 10/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.